Alva Review-Courier -

CDC, ACIP approve Novavax Covid-19 vaccine under emergency use authorization


OKLAHOMA CITY – This week, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation of the Novavax Covid-19 vaccine for primary series vaccination in adults ages 18 and older.

Novavax is a two-dose, protein-based Covid-19 vaccine, adding another option to the Pfizer and Moderna mRNA vaccines and the Johnson & Johnson viral-vector vaccine.

“Protein subunit vaccines contain harmless pieces (proteins) of the Covid-19 virus alongside another ingredient, called an adjuvant, that helps the immune system respond to...

For access to this article please sign in or subscribe.


Reader Comments(0)


Our Family of Publications Includes:


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2022